Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Clinical and Experimental Rheumatology|April 1, 1984
Primary systemic amyloidosis with a retroperitoneal massS Idell, M Meltzer, E Knafelc, et al.
International Pharmacopsychiatry|January 1, 1980
A double-blind comparison of three dosages of flutroline (CP-36,584) in the treatment of schizophreniaJ P McEvoy, S Berney, W H Wilson, et al.
Clinical and Diagnostic Laboratory Immunology|September 3, 1999
Increased levels of alternatively spliced interleukin 4 (IL-4delta2) transcripts in peripheral blood mononuclear cells from patients with systemic sclerosisL I Sakkas, C Tourtellotte, S Berney, et al.
Pharmacopsychiatria|May 1, 1982
Bromperidol maintenance in schizophreniaJ P McEvoy, W H Wilson, T A Ban, et al.
The Journal of Clinical Psychiatry|March 1, 1982
Viloxazine HCl in the treatment of endogenous depression: a standard (imipramine) controlled clinical studyJ P McEvoy, J Libiger, W H Wilson, et al.
Neurobehavioral Toxicology and Teratology|July 1, 1984
Microcomputer-assisted open field measures of rats given ethanol on postnatal days 1-8T B Sonderegger, A J Ritchie, S Berney-Key, et al.
Molecular Medicine (Cambridge, Mass.)|November 1, 1994
Clonal hematopoiesis and acquired thalassemia in common variable immunodeficiencyM Belickova, H W Schroeder, Y L Guan, et al.
Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association|April 30, 2019
Associations between nutritional energy delivery, bioimpedance spectroscopy and functional outcomes in survivors of critical illnessK Fetterplace, L J Beach, C MacIsaac, et al.
Critical Care (London, England)|November 7, 2023
Inflammation and altered metabolism impede efficacy of functional electrical stimulation in critically ill patientsT S O Jameson, M K Caldow, F Stephens, et al.
Pageof 3